Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Neutralising antibodies analysis

Known as: neutralising antibodies, neutralizing antibodies 
 
National Institutes of Health

Related topics

Related topics

2 relations
Antibodies, BlockingAntibodies, Neutralizing

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models.
Adeno-associated virus (AAV)-based vectors are promising gene delivery vehicles for human gene transfer. One significant obstacle… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
Human cytomegalovirus (HCMV), a herpesvirus, is a ubiquitously distributed pathogen that causes severe disease in… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
The pleiotropic effects of natural AAV infections on liver-directed gene transfer in macaques.
Adeno-associated viral (AAV) vectors hold great potential for liver-directed gene therapy. Stable and high levels of transgene… Expand
Is this relevant?
Review
2008
Review
2008
The challenge of PRRS immunology
Abstract Porcine reproductive and respiratory syndrome (PRRS) is one of the most challenging subjects of research in… Expand
  • table 1
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy.
In a clinical study of recombinant adeno-associated virus-2 expressing human factor IX (AAV2-FIX), we detected 2 impediments to… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
A randomized, double-blind, dose-comparison study of weekly interferon β-1a in relapsing MS
Background: Interferon β-1a (IFNβ-1a; Avonex) is effective for the treatment of relapsing MS; however, the optimal dose of IFN… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory
Objective: To evaluate the incidence and the prevalence of neutralising antibodies (NABs) to three interferon beta (IFN… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Ebola Virus Glycoprotein: Proteolytic Processing, Acylation, Cell Tropism, and Detection of Neutralizing Antibodies
ABSTRACT Using the vesicular stomatitis virus (VSV) pseudotype system, we studied the functional properties of the Ebola virus… Expand
  • figure 1
  • figure 2
  • table 3
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Evaluation of bioavailability of three types of IFNbeta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification.
Intracellular expression of human myxovirus protein A (MxA) is exclusively induced by type I IFNs (IFNalpha,beta,omega) or by… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis
Background: Interferon beta is an effective treatment for relapsing multiple sclerosis(MS). As with other protein drugs… Expand
  • table 1
  • table 3
  • table 2
  • table 4
  • table 5
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE